149 related articles for article (PubMed ID: 31242439)
1. Dopamine D
Yang L; Yao Y; Yong L; Feng Y; Su H; Yao Q; Xue J; Lu W; Zhou T
Eur J Pharmacol; 2019 Sep; 859():172499. PubMed ID: 31242439
[TBL] [Abstract][Full Text] [Related]
2. QAP14 suppresses breast cancer stemness and metastasis via activation of dopamine D1 receptor.
Yong L; Yao Y; Chen GS; Yan XX; Guo YC; Han MY; Xue JS; Jian WZ; Zhou TY
Acta Pharmacol Sin; 2022 Apr; 43(4):1001-1012. PubMed ID: 34183757
[TBL] [Abstract][Full Text] [Related]
3. L-Stepholidine rescues memory deficit and synaptic plasticity in models of Alzheimer's disease via activating dopamine D1 receptor/PKA signaling pathway.
Hao JR; Sun N; Lei L; Li XY; Yao B; Sun K; Hu R; Zhang X; Shi XD; Gao C
Cell Death Dis; 2015 Nov; 6(11):e1965. PubMed ID: 26539912
[TBL] [Abstract][Full Text] [Related]
4. [Effects of l-stepholidine on the peripheral vascular dopamine DA1 and DA2 receptor subtypes].
Zhang W; Zhi J; Guo W; Zhao R; Jin G
Yao Xue Xue Bao; 1998 Oct; 33(10):721-6. PubMed ID: 12016922
[TBL] [Abstract][Full Text] [Related]
5. Dual actions of (-)-stepholidine on the dopamine receptor-mediated adenylate cyclase activity in rat corpus striatum.
Dong ZJ; Guo X; Chen LJ; Han YF; Jin GZ
Life Sci; 1997; 61(4):465-72. PubMed ID: 9244373
[TBL] [Abstract][Full Text] [Related]
6. l-Stepholidine increases the frequency of sEPSC via the activation of D1 dopamine signaling pathway in rat prelimbic cortical neurons.
Gao M; Liu CL; Yang S; Zhen XC; Jin GZ
Acta Pharmacol Sin; 2007 May; 28(5):627-33. PubMed ID: 17439718
[TBL] [Abstract][Full Text] [Related]
7. Involvement of dopamine D1 and D2 receptors in Fos immunoreactivity induced by stepholidine in both intact and denervated striatum of lesioned rats.
Guo X; Ding YM; Hu JY; Jin GZ
Life Sci; 1998; 62(25):2295-302. PubMed ID: 9651118
[TBL] [Abstract][Full Text] [Related]
8. Effects of l-stepholidine on forebrain Fos expression: comparison with clozapine and haloperidol.
Mo YQ; Jin XL; Chen YT; Jin GZ; Shi WX
Neuropsychopharmacology; 2005 Feb; 30(2):261-7. PubMed ID: 15578005
[TBL] [Abstract][Full Text] [Related]
9. (-)-Stepholidine acts as a D1 partial agonist on firing activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine-lesioned rats.
Sun BC; Zhang XX; Jin GZ
Life Sci; 1996; 59(4):299-306. PubMed ID: 8761001
[TBL] [Abstract][Full Text] [Related]
10. L-Stepholidine, a naturally occurring dopamine D1 receptor agonist and D2 receptor antagonist, attenuates heroin self-administration and cue-induced reinstatement in rats.
Yue K; Ma B; Chen L; Tian X; Ru Q; Gan Y; Wang D; Jin G; Li C
Neuroreport; 2014 Jan; 25(1):7-11. PubMed ID: 24145772
[TBL] [Abstract][Full Text] [Related]
11. Z1046: biochemical characterization of its dopaminergic activity.
Fantoni M; Moriggi E; Bisiani C; Masotto C; Pocchiari F; Semeraro C
Acta Physiol Hung; 1996; 84(3):279-80. PubMed ID: 9219606
[TBL] [Abstract][Full Text] [Related]
12. L-stepholidine, a natural dopamine receptor D1 agonist and D2 antagonist, inhibits heroin-induced reinstatement.
Ma B; Yue K; Chen L; Tian X; Ru Q; Gan Y; Wang D; Jin G; Li C
Neurosci Lett; 2014 Jan; 559():67-71. PubMed ID: 24269875
[TBL] [Abstract][Full Text] [Related]
13. Desensitization of human renal D1 dopamine receptors by G protein-coupled receptor kinase 4.
Watanabe H; Xu J; Bengra C; Jose PA; Felder RA
Kidney Int; 2002 Sep; 62(3):790-8. PubMed ID: 12164861
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D1A receptors and renin release in rat juxtaglomerular cells.
Yamaguchi I; Yao L; Sanada H; Ozono R; Mouradian MM; Jose PA; Carey RM; Felder RA
Hypertension; 1997 Apr; 29(4):962-8. PubMed ID: 9095084
[TBL] [Abstract][Full Text] [Related]
15. Comparison of (-)-stepholidine and D1 or D2 agonists on unit firing of globus pallidus in 6-hydroxydopamine-lesioned rats.
Zhang XX; Zhu ZT; Jin GZ
Life Sci; 1998; 63(7):537-44. PubMed ID: 9718079
[TBL] [Abstract][Full Text] [Related]
16. Effects of dopamine receptor agonists on the cAMP content in arteries of the rabbit.
Zhu L; Zhao RR; Zhang WF
Sheng Li Xue Bao; 2000 Jun; 52(3):247-51. PubMed ID: 11956574
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D1 receptor augmentation of D3 receptor action in rat aortic or mesenteric vascular smooth muscles.
Zeng C; Wang D; Yang Z; Wang Z; Asico LD; Wilcox CS; Eisner GM; Welch WJ; Felder RA; Jose PA
Hypertension; 2004 Mar; 43(3):673-9. PubMed ID: 14769810
[TBL] [Abstract][Full Text] [Related]
18. Nonlinear analysis of partial dopamine agonist effects on cAMP in C6 glioma cells.
Avalos M; Mak C; Randall PK; Trzeciakowski JP; Abell C; Kwan SW; Wilcox RE
J Pharmacol Toxicol Methods; 2001; 45(1):17-37. PubMed ID: 11489662
[TBL] [Abstract][Full Text] [Related]
19. Modulation of medical prefrontal cortical D1 receptors on the excitatory firing activity of nucleus accumbens neurons elicited by (-)-Stepholidine.
Zhu ZT; Fu Y; Hu GY; Jin GZ
Life Sci; 2000 Aug; 67(11):1265-74. PubMed ID: 10972195
[TBL] [Abstract][Full Text] [Related]
20. Dopamine enhances the response of sunitinib in the treatment of drug-resistant breast cancer: Involvement of eradicating cancer stem-like cells.
Wang S; Mou Z; Ma Y; Li J; Li J; Ji X; Wu K; Li L; Lu W; Zhou T
Biochem Pharmacol; 2015 May; 95(2):98-109. PubMed ID: 25824241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
